Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2021

View Archived Issues

Wuhan LL Science and Technology Development Co. patents P2X4 receptor antagonists

New GTPase KRAS inhibitors discovered at REVOLUTION Medicines

Kyorin Pharmaceutical and collaborators describe protein G9a inhibitors

Sinovent identifies new GTPase KRAS G12C mutant inhibitors

New CDK8 and/or CDK19 inhibitors synthesized at the Dana-Farber Cancer Institute

Karuna reports phase Ib data on KarXT in healthy elderly volunteers

XBiotech initiates trial of XB-2001 with chemotherapy for pancreatic cancer

First-in-human study of BDB-018 explores use in advanced solid tumors

Seal Rock begins phase I trial of SRT-015 for NASH

Titan reports in vivo data on TP-2021 implant in model of chronic pruritus

Mercaptor advances programs in COVID-19 brain inflammation and epilepsy

Study supports miR panel for diagnosing multiple sclerosis

CStone reports data on Gavreto in Chinese patients with advanced RET fusion-positive NSCLC

Fulcrum reports phase IIb data on losmapimod in FSHD

Sellas reports phase I data on galinpepimut-S with nivolumab in malignant pleural mesothelioma

Kaken begins Japanese phase I study of sofpironium bromide gel in primary palmoplantar hyperhidrosis

Back to the basics for new insights, with new technology

Applied Genetic Technologies reports 12-month data from phase I/II achromatopsia trials

Follicum discontinues development of FOL-005 for alopecia

Aravive advances phase Ib evaluation of AVB-500 with cabozantinib in clear cell renal cel carcinoma

Arcus provides interim analysis from ARC-7 study of domvanalimab combinations in NSCLC

Dosing begins in phase II study of ALPN-101 in SLE

First patient enters phase II study of TG-4001 with avelumab in HPV16-positive anogenital tumors

IN3BIO cleared to begin phase I/II trial of IN-01 for colorectal cancer in Bulgaria

Abivax reports phase IIa data on ABX-464 in rheumatoid arthritis

SelectImmune Pharma and Lonza collaborate to develop processes for novel immunotherapy protein NlpD

Carmot opens phase I study of dual GLP-1 and GIP receptor modulator CT-388

Bristol Myers Squibb exercises option to U.S. license for Prothena's PRX-005

4D Molecular Therapeutics reports pipeline update

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...